RE:RE:RE:RE:Another Director Buys Shares in the Open Market I will not argue that I know the rules and do not have time to go through that whole document (an excerpt would have been appreciated), but there are more than a dozen exemptions to the insider reporting cited in that document. If this is something that truly bothers you, why not just e-mail or call Josh Berg (415-205-7891 or info@heliusmedical.com)? I have usually found, and specifically with Helius, that some of the issues I thought of having "uncovered" were really not, and a simple call reassured me.
The reason why was possibly harsh in my initial reply, is that I have known these guys for almost three years now and not a single time have they done something wrong, lied or misrepresented facts. They are some of the most trustworthy people I know. Thus your comment on "another sign of inadequate reporting - not a confidence builder" seemed out of line. Btw, what other signs have you uncovered?
Prokofiev
miningfundi wrote: I was refering to SEDI (not SEDAR). Helius is a Reporting Issuer in Ontario and must, and does, file on SEDI, but nothing has been filed for 2017. Refer to OSC NI 55-104 https://www.osc.gov.on.ca/documents/en/Securities-Category5/rule_20170201_55-104_reporting-requirements-exemptions.pdf
prokofiev wrote: Cool story bro...Helius files on Edgar, not Sedar... so please do your homework next time before posting..
https://yahoo.brand.edgar-online.com/default.aspx?cik=1610853 Prokofiev
miningfundi wrote: Neither Andreeff nor Blane have yet filed their HSM share purchases on SEDI (required to file within 5 days). Andreeff has not even filed as a director (required to file within 10 days). Another sign of inadequate reporting - not a confidence builder.
prokofiev wrote: Director Walter R Blane recently bought 40,000 shares at $3.08. This is the now the second Director to buy shares following the release of the trial results.
Prokofiev